1161000-19-6

Basic information

• Product Name: (6S,8R)-8-Hydroxy-1,4-diazabicyclo-[4.3.0]nonane
• Synonyms: (6S,8R)-8-Hydroxy-1,4-diazabicyclo-[4.3.0]nonane;(7R,8aS)-rel-Octahydropyrrolo[1,2-a]pyrazin-7-ol
• CAS NO: 1161000-19-6
• Molecular Formula: C7H14N2O
• Molecular Weight: 142.19886
• Mol File: 1161000-19-6.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (6S,8R)-8-Hydroxy-1,4-diazabicyclo-[4.3.0]nonane(CAS DataBase Reference)
• NIST Chemistry Reference: (6S,8R)-8-Hydroxy-1,4-diazabicyclo-[4.3.0]nonane(1161000-19-6)
• EPA Substance Registry System: (6S,8R)-8-Hydroxy-1,4-diazabicyclo-[4.3.0]nonane(1161000-19-6)

Safety Data

• Hazardous Substances Data: 1161000-19-6(Hazardous Substances Data)

Usage

General Description

(6S,8R)-8-Hydroxy-1,4-diazabicyclo[4.3.0]nonane, also known as (6S,8R)-8-hydroxybicyclo[4.3.0]nonane-1,4-dione, is a chemical compound with a bicyclic structure containing a hydroxy group. It is a chiral molecule with an (6S,8R) stereochemistry. (6S,8R)-8-Hydroxy-1,4-diazabicyclo-[4.3.0]nonane is commonly used as a ligand in organic chemistry and is of interest for its potential biological and pharmacological properties. Its unique structure and stereochemistry make it a valuable tool for studying molecular interactions and for the development of new pharmaceuticals. Additionally, (6S,8R)-8-Hydroxy-1,4-diazabicyclo[4.3.0]nonane has potential applications in asymmetric synthesis and catalysis due to its chiral nature.

Upstream product

• 40216-83-9 L-4-hydroxyproline methyl ester hydrochloride 
• 51-35-4 4R-4-hydroxyproline 
• 13726-69-7 (2S,4R)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid 
• 481704-21-6 (2R,4S)-methyl 4-hydroxypyrrolidine-2-carboxylate hydrochloride 
• 142347-81-7 (2R,4S)-4-hydroxypyrrolidine-2-carboxylic acid hydrochloride 
• 1429199-82-5 (7S,8aR)-2-benzyl-7-hydroxyhexahydropyrrolo[1,2-a]pyrazine-1,4-dione 
• 1429199-83-6 (7S,8aR)-2-benzyloctahydropyrrolo[1,2-a]pyrazin-7-ol 
• 1429199-81-4 (2R,4S)-methyl 1-(2-chloroacetyl)-4-hydroxypyrrolidine-2-carboxylate 
• 132714-97-7 (7R,8aS)-2-benzyl-7-hydroxyhexahydropyrrolo[1,2-a]pyrazine-1,4-dione 
• 132715-17-4 (2S,4R)-methyl 1-(2-chloroacetyl)-4-hydroxypyrrolidine-2-carboxylate 
• 132715-08-3 (6S,8R)-4-benzyl-8-hydroxy-1,4-diazabicyclo<4.3.0>nonane 
• 879399-06-1 (7R,8aS)-1,4-dioxooctahydropyrrolo[1,2-a]pyrazin-7-yl benzoate 

Downstream Products

• 1429199-26-7 (7S,8aR)-2-{[4-(trifluoromethyl)phenyl]sulfonyl}octahydropyrrolo[1,2-a]-pyrazin-7-ol 
• 1429197-85-2 (7R,8aR)-7-[(5-cyclopropylpyrazin-2-yl)oxy]-2-{[3-(trifluoromethyl)phenyl]-sulfonyl}octahydropyrrolo[1,2-a]pyrazine 
• 1429196-79-1 (7S,8aR)-7-[(5-cyclopropylpyrazin-2-yl)oxy]-2-{[3-(trifluoromethyl)phenyl]-sulfonyl}octahydropyrrolo[1,2-a]pyrazine 
• 1429199-52-9 (7R,8aS)-7-{[5-(1-methylcyclopropyl)pyrazin-2-yl]oxy}-2-{[3-(trifluoromethyl)phenyl]sulfonyl}octahydropyrrolo[1,2-a]pyrazine 
• 1429199-72-3 (7R,8aS)-2-{[4-(trifluoromethyl)phenyl]sulfonyl}-7-{[5-(trifluoromethyl)-pyridin-2-yl]oxy}octahydropyrrolo[1,2-a]pyrazine 
• 1204603-42-8 (7R,8aS)-tert-butyl 7-hydroxyhexahydropyrrolo[1,2-a]pyrazine-2(1H)-carboxylate 
• 1429295-24-8 [(7R,8aS)-7-hydroxyhexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl][3-(trifluoromethyl)phenyl]methanone 
• 1429295-25-9 [(7R,8aS)-7-[(5-chloropyridin-2-yl)oxy]hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl][3-(trifluoromethyl)phenyl]methanone 
• 1429296-21-8 1-[(7R,8aS)-7-[(5-isopropylpyrazin-2-yl)oxy]hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-2-[3-(trifluoromethyl)phenyl]ethanone 
• 1429296-13-8 1-[(7R,8aS)-7-{[5-(prop-1-en-2-yl)pyrazin-2-yl]oxy}hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-2-[3-(trifluoromethyl)phenyl]ethanone 
• 1429295-52-2 (7R,8aS)-7-[(5-chloropyridin-2-yl)oxy]-2-[3-(trifluoromethyl)benzyl]octahydropyrrolo[1,2-a]pyrazine 

Relevant articles and documents

Carbostyril carboxylic compounds and intermediates, preparation method and application thereof

The invention discloses carbostyril carboxylic compounds and hydrochlorides thereof and also discloses a preparation method of the compounds and the hydrochlorides thereof as well as an application of the compounds and the hydrochlorides thereof in preparing gram-positive bacterium-preventing or gram-negative bacterium-preventing drugs. Moreover, the invention discloses intermediates for preparing the compounds and a preparation method of the intermediates.

SUBSTITUTED OCTAHYDROPYRROLO[1,2-A]PYRAZINE SULFONAMIDES AS CALCIUM CHANNEL BLOCKERS

The present application relates to: (a) compounds of Formula (I): (I), and salts thereof, wherein Z', Z", L2, G2, R1, and R2 are as defined in the specification; (b) compositions comprising such compounds and salts; and (c) methods of use of such compounds, salts, and compositions, particularly use as calcium channel blockers.

INHIBITORS OF THE HIV INTEGRASE ENZYME

The present invention relates to compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, pharmaceutical compositions comprisingm compounds of formula (I), and their methods of use in treating HIV-infected mammals.